Navigating Uncertainty and Driving Innovation

© Aleksandr Matveev - stock.adobe.com

At CPhI Frankfurt, Christene Smith from CHEManager International spoke with Arul Ramadurai, CCO, Axplora, about how the company is responding to the challenges and opportunities facing the pharmaceutical industry. Ramadurai shares insights on adapting to global uncertainty, building strategic partnerships, and advancing flexible manufacturing.

CHEManager: How is Axplora adapting to the current economic and geopolitical situation, specifically within the pharmaceutical industry?

Arul Ramadurai: The pharmaceutical industry is experiencing a period of significant uncertainty, shaped by economic and geopolitical factors. At Axplora, we see this not just as a challenge but as an opportunity to strengthen our position and better serve our customers. Unlike larger organizations with extensive public affairs teams, our approach is to stay closely connected to our clients—pharma companies and biotechs—by listening to their needs and responding quickly.
Our customers consistently emphasize the importance of speed, efficiency, and above all, reliable supply chains. In pharma, robust supply is critical, and we’ve made it our priority to ensure that our operations can deliver on this promise. Axplora’s footprint—with multiple sites across France, Germany, Italy, and India—positions us to support customers in key markets and adapt to shifting global dynamics.